Biocina Pdf Biocina is a global end to end biologics contract development and manufacturing organisation (cdmo), offering highest quality, cost effective cell line, process, analytical and formulation development, and cgmp clinical & commercial manufacturing for the microbial, pdna and mrna modalities. Quality isn’t just a goal — it’s embedded in our culture and drives everything we do. as the only biologics cdmo in australia approved by the us fda, biocina stands apart in capability and compliance. partner with us and watch your life’s work thrive.
Biocina The Org Biocina is a global end to end contract development and manufacturing organisation (cdmo) offering clients unparalleled quality, adherence to the highest regulatory standards, and. Operating under the established brand name of biocina, the newly merged organization aims to deliver an integrated suite of services. these range from cell line and process development to clinical and commercial drug substances, alongside sterile drug fill finish capabilities. Biocina, a global contract development and manufacturing organisation (cdmo), has announced a strategic merger with novacina. the merger integrates both companies’ expertise to deliver a seamless suite of end to end manufacturing solutions for the biopharmaceutical and small molecule industries. We are a global contract development and manufacturing organization with a rich history of providing end to end biologics solutions. we offer process development and cgmp clinical and commercial manufacturing for microbial, pdna, and mrna programs.
News Biocina Biocina, a global contract development and manufacturing organisation (cdmo), has announced a strategic merger with novacina. the merger integrates both companies’ expertise to deliver a seamless suite of end to end manufacturing solutions for the biopharmaceutical and small molecule industries. We are a global contract development and manufacturing organization with a rich history of providing end to end biologics solutions. we offer process development and cgmp clinical and commercial manufacturing for microbial, pdna, and mrna programs. Biocina is a global end to end contract development and manufacturing organisation (cdmo) offering clients unparalleled quality, adherence to the highest regulatory standards, and industry leading on time and in full delivery, setting a new benchmark in the industry for quality and reliability. Mark w. womack is an experienced executive in the biopharmaceutical and management consulting sectors, currently serving as chief executive officer at biocina and a board member for lumacina and novacina. Biocina pty ltd. is a global contract development and manufacturing organization (cdmo) with a focus on the development and cgmp manufacture of microbial based biological pharmaceuticals, including proteins, plasmid dna, mrna, vaccines, and biosimilars. Jason arcediano is an accomplished executive with extensive experience in the biopharmaceutical industry, currently serving as chief commercial officer at biocina since february 2025.
Comments are closed.